AIM
Alerce Investment Management Portfolio holdings
AUM
$56.8M
This Quarter Return
+40.05%
1 Year Return
+31.17%
3 Year Return
+25.12%
5 Year Return
–
10 Year Return
–
AUM
$104M
AUM Growth
+$104M
(+93%)
Cap. Flow
+$46.7M
Cap. Flow
% of AUM
44.97%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
4
Reduced
–
Closed
–
Top Buys
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$15.7M |
| 2 |
Annexon
ANNX
|
$15.2M |
| 3 |
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
|
$13M |
| 4 |
American Well
AMWL
|
$2.87M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Annexon
ANNX
$226M
| $27.2M | 26.24% |
4,408,966
+2,453,988
| +126% | +$15.2M |
|
|
2
American Well
AMWL
$111M
| $25.5M | 24.55% |
7,100,773
+800,000
| +13% | +$2.87M |
|
|
GBT
3
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $24.3M | 23.36% |
356,270
+230,000
| +182% | +$15.7M |
|
|
WHWK
4
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $18.3M | 17.62% |
1,294,785
+920,000
| +245% | +$13M |
|
5
Assembly Biosciences
ASMB
$190M
| $3.65M | 3.52% |
2,227,500
| – | – |
|
|
RNTX
6
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $3.43M | 3.31% |
16,609,449
| – | – |
|
7
Akebia Therapeutics
AKBA
$833M
| $1.47M | 1.42% |
4,652,561
| – | – |
|